Literature DB >> 7666500

The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture.

S Schmolke1, H F Kern, P Drescher, G Jahn, B Plachter.   

Abstract

The phosphoprotein pp65 (ppUL83) of human cytomegalovirus (HCMV) is abundantly synthesized during lytic infection in cultured fibroblasts. As a major constituent of extracellular particles, it gains entry to infected cells immediately after adsorption and subsequently translocates to the cell nucleus. This efficient transport is mediated by unique nuclear localization signals. To study the function of pp65, a viral deletion mutant was constructed by replacing the pp65 gene with the bacterial neomycin phosphotransferase gene, driven by the simian virus 40 early promoter. The resulting virus, RVAd65, could be grown and selected on human fibroblasts without complementation. The deletion of the pp65 gene in RVAd65 was verified by using Southern blot and PCR analyses. The lack of expression from the gene was investigated by immunoblotting with pp65-specific monoclonal antibodies. Single-cycle growth analyses showed that RVAd65 grew to levels of infectivity comparable to those of the wild-type virus. Therefore, pp65 is nonessential for the growth of HCMV in human fibroblasts. Electron microscopy revealed no differences in the processes of virion morphogenesis, although the maturation appeared to be delayed. However, the kinetics of expression of the immediate-early genes UL122 and UL123, the early gene UL44, and the late gene UL32 were the same in RVAd65-infected cells as in wild-type virus-infected cells in immunoblot analyses. In vitro phosphorylation assays showed that some of the virion proteins were labelled to a markedly reduced extent by virion-associated kinases in RVAd65 compared with wild-type virus. We therefore conclude that although deletion of the pp65 gene does not abolish replication of HCMV, a recombinant virus lacking pp65 displays phenotypic alterations compared with wild-type virus during growth in cultured fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666500      PMCID: PMC189491     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events.

Authors:  A P Geballe; F S Leach; E S Mocarski
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.

Authors:  A Irmiere; W Gibson
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

4.  Isolation and partial chemical characterization of a 64,000-dalton glycoprotein of human cytomegalovirus.

Authors:  B R Clark; J A Zaia; L Balce-Directo; Y P Ting
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

5.  On the intracellular transport and the nuclear association of human cytomegalovirus structural proteins.

Authors:  M Yamauchi; Y Nishiyama; H Fujioka; S Isomura; K Maeno
Journal:  J Gen Virol       Date:  1985-04       Impact factor: 3.891

6.  Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.

Authors:  M P Landini; M C Re; G Mirolo; B Baldassarri; M La Placa
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

7.  Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted.

Authors:  H Browne; M Churcher; T Minson
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Human cytomegalovirus-associated DNA polymerase and protein kinase activities.

Authors:  E C Mar; P C Patel; E S Huang
Journal:  J Gen Virol       Date:  1981-11       Impact factor: 3.891

9.  Protein counterparts of human and simian cytomegaloviruses.

Authors:  W Gibson
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

10.  Physical mapping of human cytomegalovirus genes: identification of DNA sequences coding for a virion phosphoprotein of 71 kDa and a viral 65-kDa polypeptide.

Authors:  B Nowak; A Gmeiner; P Sarnow; A J Levine; B Fleckenstein
Journal:  Virology       Date:  1984-04-15       Impact factor: 3.616

View more
  71 in total

1.  Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents.

Authors:  M Marschall; M Freitag; S Weiler; G Sorg; T Stamminger
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).

Authors:  R Holtappels; J Podlech; N K Grzimek; D Thomas; M F Pahl-Seibert; M J Reddehase
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Molecular characterization of the guinea pig cytomegalovirus UL83 (pp65) protein homolog.

Authors:  M R Schleiss; A McGregor; N J Jensen; G Erdem; L Aktan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

4.  Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.

Authors:  Mark N Prichard; William J Britt; Shannon L Daily; Caroll B Hartline; Earl R Kern
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  New genes from old: redeployment of dUTPase by herpesviruses.

Authors:  Andrew J Davison; Nigel D Stow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles.

Authors:  Kerstin Lorz; Heike Hofmann; Anja Berndt; Nina Tavalai; Regina Mueller; Ursula Schlötzer-Schrehardt; Thomas Stamminger
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression.

Authors:  R Travis Taylor; Wade A Bresnahan
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

9.  Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.

Authors:  Rike Webel; Morgan Hakki; Mark N Prichard; William D Rawlinson; Manfred Marschall; Sunwen Chou
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).

Authors:  Alistair McGregor; Fenyong Liu; Mark R Schleiss
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.